cart

0.00
HPLC testedCOA every batchEU shippingSEPA · secure paymentResearch Use Only
PEPTIQA BIOTECHSelank10 mgPurity 98.5% · RUO

Excellent

Rating 4.8 / 5 — early quality score

Peptiqa Reviews

Early quality score — buyers can leave a review after verified purchase.

Selank

10 mg98.5% purityLot #SELANK-2026-001

SKU of selected dimension: PEP-SELANK-10MG

Selank is a laboratory-developed heptapeptide with anxiolytic properties, originally created at the Institute of Molecular Genetics of the Russian Academy of Sciences. Its structure is derived from tuftsin, a naturally occurring immunomodulatory peptide (threonyl-lysyl-prolyl-arginine), which was modified by adding a Gly-Pro fragment to improve stability and biological activity. Through its influence on both GABAergic and serotonergic signaling pathways, Selank produces pronounced anti-anxiety effects that have been shown to be comparable to benzodiazepines, yet without causing sedation, cognitive dulling, or dependency. In Russia, Selank has been approved as a prescription treatment for generalized anxiety disorder. Studies further indicate that it promotes BDNF (Brain-Derived Neurotrophic Factor) production, supports memory formation, and regulates IL-6 cytokine activity, contributing to both neurological and immune benefits.
€67.10incl. VAT
In Stock (40)

Volume pricing

QuantityUnit priceSavings
1 vial67.10
3 vials (−7%)62.22−7%
5 vials (−12%)58.56−13%
Purchase & earn 55 points!

Ratings & reviews

Log in to rate this product after your order arrives. login

Certificate of Analysis

Lab Verified
View certificate before purchase — transparency guaranteed
Research Profile

Selankscientific profile

Content is for educational and research purposes. Research Use Only.

  • Selank is a laboratory-developed heptapeptide with anxiolytic properties, originally created at the Institute of Molecular Genetics of the Russian Academy of Sciences. Its structure is derived from tuftsin, a naturally occurring immunomodulatory peptide (threonyl-lysyl-prolyl-arginine), which was modified by adding a Gly-Pro fragment to improve stability and biological activity. Through its influence on both GABAergic and serotonergic signaling pathways, Selank produces pronounced anti-anxiety effects that have been shown to be comparable to benzodiazepines, yet without causing sedation, cognitive dulling, or dependency. In Russia, Selank has been approved as a prescription treatment for generalized anxiety disorder. Studies further indicate that it promotes BDNF (Brain-Derived Neurotrophic Factor) production, supports memory formation, and regulates IL-6 cytokine activity, contributing to both neurological and immune benefits.

More from Nootropiki

This site uses cookies

Accept